ConductScience.org, home

Paper1968250

Amperozide--a new putatively antipsychotic drug with a limbic mode of action on dopamine mediated behaviour.

Gustafsson B and 1 other. Pharmacol Toxicol, 1990. Cited by 52 papers, by iCite.

Cite this record

ConductScience Library. Amperozide--a new putatively antipsychotic drug with a limbic mode of action on dopamine mediated behaviour. Papers, record 1968250. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1968250

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Amperozide--a new putatively antipsychotic drug with a limbic mode of action on dopamine mediated behaviour.
PubMed
Journal
Pharmacol Toxicol
PubMed
Year
1990
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
52
iCite
Relative citation ratio, by iCite
2.51
iCite
Revised in PubMed
2019-09-03
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gustafsson BB
2Christensson EE

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Behavior, AnimalMajor topic
DopamineMajor topic
Limbic SystemMajor topic
PiperazinesMajor topic
Psychotropic DrugsMajor topic
Animals
Antipsychotic Agents
Catalepsy
Dextroamphetamine
Exploratory Behavior
Female
Mice
Motor Activity
Rats
Rats, Inbred Strains
Stereotyped Behavior

Source PubMed

Download CSV of topics

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 52 citations.

PMIDTitleJournalYearIn PapersSource
19885000YKP1447, A Novel Potential Atypical Antipsychotic Agent.Korean J Physiol Pharmacol2009https://conductscience.org/library/papers/19885000PubMed
17684494Quetiapine facilitates oligodendrocyte development and prevents mice from myelin breakdown and behavioral changes.Mol Psychiatry2008https://conductscience.org/library/papers/17684494PubMed
7862887Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortex.Psychopharmacology (Berl)1994https://conductscience.org/library/papers/7862887PubMed
7831440The role of serotonin in schizophrenia: an overview of the nomenclature, distribution and alterations of serotonin receptors in the central nervous system.Psychopharmacology (Berl)1993https://conductscience.org/library/papers/7831440PubMed
2572972The putatively antipsychotic agent amperozide produces behavioural stimulation in the rat. A behavioural and biochemical characterization.Naunyn Schmiedebergs Arch Pharmacol1989https://conductscience.org/library/papers/2572972PubMed
1365865Amperozide and clozapine but not haloperidol or raclopride increase the secretion of oxytocin in rats.Psychopharmacology (Berl)1992https://conductscience.org/library/papers/1365865PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1968250

GET https://conductscience.org/api/papers/v1/1968250/authors